DaVita HealthCare Company Insiders
DVA Stock | USD 127.82 1.71 1.36% |
DaVita HealthCare's insiders are aggressively selling. The analysis of insiders' sentiment of trading DaVita HealthCare Partners stock suggests that vertually all insiders are panicking at this time. DaVita HealthCare employs about 70 K people. The company is managed by 42 executives with a total tenure of roughly 305 years, averaging almost 7.0 years of service per executive, having 1666.67 employees per reported executive.
Javier Rodriguez CEO Chief Executive Officer, Director |
Craig Samitt CEO Executive Vice President; CEO of HealthCare Partners |
DaVita HealthCare's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-02-26 | Javier Rodriguez | Disposed 67603 @ 126.11 | View | ||
2024-02-21 | Michael David Staffieri | Disposed 29488 @ 119.81 | View | ||
2024-02-16 | James O Hearty | Disposed 26164 @ 119.64 | View | ||
2023-12-14 | Jerry Moran | Disposed @ 107.18 | |||
2023-12-12 | Tommy Tuberville | Disposed @ 108.48 | |||
2023-08-22 | Kathleen Alyce Waters | Disposed 9794 @ 101.81 | View | ||
2023-06-12 | Tommy Tuberville | Disposed @ 97.09 | |||
2023-05-12 | Phyllis R Yale | Disposed 2196 @ 95.26 | View | ||
2023-05-10 | Javier Rodriguez | Disposed 16916 @ 99.44 | View |
Monitoring DaVita HealthCare's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
DaVita |
DaVita HealthCare's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with DaVita HealthCare's future performance. Based on our forecasts, it is anticipated that DaVita will maintain a workforce of about 70000 employees by May 2024.DaVita HealthCare's latest congressional trading
Congressional trading in companies like DaVita HealthCare, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in DaVita HealthCare by those in governmental positions are based on the same information available to the general public.
2023-12-14 | Senator Jerry Moran, | Acquired Under $15K | Verify | ||
2023-12-12 | Senator Thomas H Tuberville | Acquired Under $15K | Verify | ||
2021-12-21 | Senator Jerry Moran | Acquired Under $15K | Verify |
DaVita HealthCare Management Team Effectiveness
The company has Return on Asset of 0.0592 % which means that on every $100 spent on assets, it made $0.0592 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3853 %, implying that it generated $0.3853 on every 100 dollars invested. DaVita HealthCare's management efficiency ratios could be used to measure how well DaVita HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, DaVita HealthCare's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Capital Employed is expected to grow to 0.15, whereas Return On Assets are forecasted to decline to 0.04. At present, DaVita HealthCare's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Return On Tangible Assets is expected to grow to 0.07, whereas Total Assets are forecasted to decline to about 10.6 B.The current year's Common Stock Shares Outstanding is expected to grow to about 149.6 M, whereas Net Income Applicable To Common Shares is forecasted to decline to about 491.9 M.
DaVita HealthCare Workforce Comparison
DaVita HealthCare Partners is one of the top stocks in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 84,171. DaVita HealthCare totals roughly 70,000 in number of employees claiming about 83% of equities under Health Care industry.
DaVita HealthCare Profit Margins
The company has Net Profit Margin of 0.06 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.12 %, which entails that for every 100 dollars of revenue, it generated $0.12 of operating income.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.34 | 0.2533 |
|
| |||||
Net Profit Margin | 0.0471 | 0.057 |
|
| |||||
Operating Profit Margin | 0.17 | 0.1319 |
|
| |||||
Pretax Profit Margin | 0.08 | 0.097 |
|
| |||||
Return On Assets | 0.035 | 0.0392 |
|
| |||||
Return On Equity | 0.69 | 0.6548 |
|
|
DaVita HealthCare Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DaVita HealthCare insiders, such as employees or executives, is commonly permitted as long as it does not rely on DaVita HealthCare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, DaVita HealthCare insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-03-01 | 0.2821 | 11 | 39 | 1,654,608 | 2,989,910 |
2023-12-01 | 3.6667 | 11 | 3 | 513,154 | 894,297 |
2023-09-01 | 2.25 | 9 | 4 | 43,800 | 80,000 |
2023-06-01 | 0.5833 | 21 | 36 | 538,327 | 991,758 |
2023-03-01 | 1.5294 | 26 | 17 | 174,867 | 42,499 |
2022-12-01 | 10.0 | 10 | 1 | 10,497 | 602.00 |
2022-09-01 | 8.0 | 8 | 1 | 3,915 | 0.00 |
2022-06-01 | 0.7692 | 20 | 26 | 316,943 | 354,617 |
2022-03-01 | 3.6 | 18 | 5 | 256,996 | 6,894 |
2021-12-01 | 4.0 | 8 | 2 | 3,229 | 767.00 |
2021-09-01 | 0.9 | 9 | 10 | 184,815 | 361,881 |
2021-06-01 | 0.52 | 26 | 50 | 3,374,940 | 4,928,503 |
2021-03-01 | 10.5 | 21 | 2 | 252,360 | 10,436 |
2020-12-01 | 0.5714 | 20 | 35 | 149,764 | 322,691 |
2020-09-01 | 1.0 | 12 | 12 | 46,469 | 4,274,416 |
2020-06-01 | 0.5957 | 28 | 47 | 256,131 | 620,529 |
2020-03-01 | 2.5 | 20 | 8 | 3,235,557 | 40,679 |
2019-12-01 | 1.125 | 9 | 8 | 6,347 | 625,446 |
2019-06-01 | 2.5714 | 36 | 14 | 556,309 | 28,583 |
2018-06-01 | 1.4444 | 39 | 27 | 583,857 | 392,495 |
2018-03-01 | 1.0 | 15 | 15 | 1,242,207 | 2,377,421 |
2017-12-01 | 1.0 | 15 | 15 | 1,243,021 | 2,304,208 |
2017-06-01 | 1.8421 | 35 | 19 | 871,367 | 268,093 |
2017-03-01 | 3.25 | 13 | 4 | 296,604 | 807.00 |
2016-12-01 | 4.3333 | 13 | 3 | 95,740 | 186,447 |
2016-09-01 | 0.9412 | 16 | 17 | 64,746 | 113,838 |
2016-06-01 | 1.1563 | 37 | 32 | 1,149,336 | 1,097,114 |
2016-03-01 | 0.8889 | 16 | 18 | 422,501 | 900,719 |
2015-12-01 | 1.0 | 13 | 13 | 1,013,976 | 1,879,603 |
2015-09-01 | 0.7647 | 13 | 17 | 130,214 | 258,946 |
2015-06-01 | 1.0513 | 41 | 39 | 854,005 | 603,796 |
2015-03-01 | 0.4054 | 15 | 37 | 192,130 | 690,598 |
2014-12-01 | 0.8125 | 26 | 32 | 2,541,634 | 1,676,992 |
2014-09-01 | 1.1111 | 10 | 9 | 15,067 | 115,114 |
2014-06-01 | 1.0556 | 38 | 36 | 951,838 | 720,942 |
2014-03-01 | 0.8333 | 60 | 72 | 3,048,147 | 1,711,379 |
2013-12-01 | 9.1667 | 55 | 6 | 10,054,599 | 42,864 |
2013-09-01 | 33.0 | 33 | 1 | 1,619,954 | 0.00 |
2013-06-01 | 2.1333 | 32 | 15 | 497,454 | 812,410 |
2013-03-01 | 4.8667 | 73 | 15 | 2,380,421 | 82,500 |
2012-12-01 | 2.6977 | 116 | 43 | 4,569,362 | 1,215,218 |
2012-09-01 | 0.8333 | 40 | 48 | 1,377,764 | 2,225,488 |
2012-06-01 | 8.6667 | 26 | 3 | 102,045 | 18,750 |
2012-03-01 | 1.2593 | 34 | 27 | 191,683 | 395,704 |
2011-12-01 | 28.0 | 28 | 1 | 42,517 | 40,000 |
2011-09-01 | 1.4286 | 20 | 14 | 15,325 | 268,334 |
2011-06-01 | 0.9091 | 40 | 44 | 1,870,359 | 1,724,906 |
2011-03-01 | 0.641 | 50 | 78 | 635,741 | 1,303,590 |
2010-12-01 | 0.5465 | 47 | 86 | 650,838 | 1,328,173 |
2010-09-01 | 2.8889 | 26 | 9 | 17,377 | 30,000 |
2010-06-01 | 1.1818 | 26 | 22 | 219,489 | 274,729 |
2010-03-01 | 1.48 | 37 | 25 | 1,075,182 | 861,459 |
2009-12-01 | 1.5263 | 29 | 19 | 329,934 | 1,272,801 |
2009-09-01 | 2.125 | 17 | 8 | 39,317 | 126,016 |
2009-06-01 | 1.625 | 26 | 16 | 525,546 | 799,420 |
2009-03-01 | 2.375 | 19 | 8 | 1,451,460 | 272,506 |
2008-12-01 | 2.0 | 22 | 11 | 231,703 | 486,318 |
2008-09-01 | 0.7931 | 23 | 29 | 209,684 | 519,229 |
2008-06-01 | 0.2561 | 21 | 82 | 124,878 | 158,004 |
2008-03-01 | 0.5143 | 54 | 105 | 1,974,533 | 158,124 |
2007-12-01 | 0.1406 | 18 | 128 | 294,516 | 660,897 |
2007-09-01 | 0.0846 | 22 | 260 | 558,855 | 1,281,907 |
2007-06-01 | 0.1732 | 22 | 127 | 161,060 | 281,377 |
2007-03-01 | 0.5094 | 27 | 53 | 1,501,246 | 249,500 |
2006-12-01 | 0.1532 | 19 | 124 | 409,350 | 574,467 |
2006-09-01 | 0.2951 | 18 | 61 | 1,064,191 | 260,000 |
2006-06-01 | 0.5806 | 18 | 31 | 142,513 | 89,093 |
2006-03-01 | 0.0754 | 23 | 305 | 600,033 | 1,292,513 |
2005-12-01 | 0.4444 | 12 | 27 | 137,379 | 213,822 |
2005-09-01 | 0.4167 | 20 | 48 | 1,258,428 | 853,544 |
2005-06-01 | 0.3529 | 24 | 68 | 417,116 | 802,500 |
2005-03-01 | 0.2927 | 12 | 41 | 485,740 | 985,000 |
2004-12-01 | 1.0667 | 16 | 15 | 364,784 | 493,026 |
2004-09-01 | 1.0833 | 13 | 12 | 153,220 | 317,373 |
2004-06-01 | 0.8182 | 36 | 44 | 448,605 | 846,050 |
2004-03-01 | 0.5391 | 62 | 115 | 1,185,107 | 1,089,935 |
2003-12-01 | 0.4459 | 33 | 74 | 469,446 | 924,645 |
2003-09-01 | 0.3548 | 11 | 31 | 124,064 | 216,000 |
2003-06-01 | 1.1667 | 7 | 6 | 88,000 | 63,000 |
DaVita HealthCare Notable Stakeholders
A DaVita HealthCare stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DaVita HealthCare often face trade-offs trying to please all of them. DaVita HealthCare's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DaVita HealthCare's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Javier Rodriguez | Chief Executive Officer, Director | Profile | |
Craig Samitt | Executive Vice President; CEO of HealthCare Partners | Profile | |
Dennis Kogod | CEO of International and President of Healthcare Partners | Profile | |
Robert Margolis | Co-Chairman of the Board | Profile | |
Pamela Arway | Independent Chairman of the Board | Profile | |
Kent Thiry | Chairman, CEO and CEO of Healthcare Partners | Profile | |
Robert Lang | President International Business | Profile | |
Jim Gustafson | Vice President - Investor Relations | Profile | |
Atul Mathur | Executive Vice President of Global Operations | Profile | |
LeAnne Zumwalt | Group Vice President - purchasing and government affairs | Profile | |
James Hilger | Interim CFO and Chief Accounting Officer | Profile | |
Joel Ackerman | Chief Financial Officer, Treasurer | Profile | |
Joseph Mello | COO of HealthCare Partners | Profile | |
Michael Staffieri | Chief Operating Officer- DaVita Kidney Care | Profile | |
Paul Diaz | Independent Director | Profile | |
John Nehra | Independent Director | Profile | |
Peter Grauer | Lead Independent Director | Profile | |
Phyllis Yale | Independent Director | Profile | |
Roger Valine | Independent Director | Profile | |
Pascal Desroches | Independent Director | Profile | |
Carol Davidson | Independent Director | Profile | |
Barbara Desoer | Independent Director | Profile | |
William Roper | Independent Director | Profile | |
Charles Berg | Independent Director | Profile | |
James Hearty | Chief Compliance Officer | Profile | |
Shawn Guertin | Director | Profile | |
Paula Price | Independent Director | Profile | |
Misha Palecek | Chief Business | Profile | |
Christopher Berry | Group Officer | Profile | |
Jeffrey Giullian | Chief Care | Profile | |
John Winstel | Chief Accounting Officer, Group Vice President | Profile | |
Kenneth Smith | Chief Officer | Profile | |
Gregory Moore | Independent Director | Profile | |
David Roer | Chief Medical Officer - DaVita Integrated Kidney Care | Profile | |
FRCPC MD | Chief Operations | Profile | |
Kathleen Waters | Chief Legal and Public Affairs Officer | Profile | |
Kenny Gardner | Chief People Officer - DaVita Kidney Care | Profile | |
Kim Rivera | Chief Legal Officer | Profile | |
Mihran Naljayan | Chief Medical Officer - Home Modalities | Profile | |
Jeanine Jiganti | Chief Compliance Officer | Profile | |
Laura Mildenberger | Chief People Officer - Kidney Care | Profile | |
MSc MD | Chief International | Profile |
About DaVita HealthCare Management Performance
The success or failure of an entity such as DaVita HealthCare often depends on how effective the management is. DaVita HealthCare management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DaVita management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DaVita management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.07 | 0.07 | |
Return On Capital Employed | 0.11 | 0.15 | |
Return On Assets | 0.04 | 0.04 | |
Return On Equity | 0.65 | 0.69 |
The data published in DaVita HealthCare's official financial statements usually reflect DaVita HealthCare's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of DaVita HealthCare. For example, before you start analyzing numbers published by DaVita accountants, it's critical to develop an understanding of what DaVita HealthCare's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of DaVita HealthCare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DaVita HealthCare's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in DaVita HealthCare's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of DaVita HealthCare Partners. Please utilize our Beneish M Score to check the likelihood of DaVita HealthCare's management manipulating its earnings.
DaVita HealthCare Workforce Analysis
Traditionally, organizations such as DaVita HealthCare use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DaVita HealthCare within its industry.DaVita HealthCare Manpower Efficiency
Return on DaVita HealthCare Manpower
Revenue Per Employee | 173.4K | |
Revenue Per Executive | 289.1M | |
Net Income Per Employee | 9.9K | |
Net Income Per Executive | 16.5M | |
Working Capital Per Employee | 7.1K | |
Working Capital Per Executive | 11.8M |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for DaVita Stock analysis
When running DaVita HealthCare's price analysis, check to measure DaVita HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DaVita HealthCare is operating at the current time. Most of DaVita HealthCare's value examination focuses on studying past and present price action to predict the probability of DaVita HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DaVita HealthCare's price. Additionally, you may evaluate how the addition of DaVita HealthCare to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is DaVita HealthCare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.2 | Earnings Share 7.42 | Revenue Per Share 133.717 | Quarterly Revenue Growth 0.078 | Return On Assets 0.0592 |
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.